Amy Mahery is an accomplished healthcare executive with extensive experience in commercial leadership within the biopharmaceutical industry. Currently serving as Chief Commercial Officer at Roivant Sciences, Amy has also held pivotal roles such as Director on the Board at CNS Pharmaceuticals, Inc. and Advisor at NeuroX1 Inc. Previously, significant contributions were made at EMD Serono, Inc. as Senior Vice President, overseeing the Global Business Franchise for Neurology & Immunology, as well as holding leadership positions in Global Market Access and Pricing. Early career experiences include roles at Johnson & Johnson (McNeil Specialty) as a Senior Sales Training Specialist and Specialty Sales Representative. Amy holds a B.S. in Neuroscience from Trinity College-Hartford and has furthered education at INSEAD.